Lipase Inhibitors

Lipase Inhibitors — compiles small compounds such as Orlistat, Cetilistat, and urea and carbamate derivatives that work by inhibiting lipase enzyme activity, both pancreatic lipase and monoacylglycerol lipase (MAGL). This class serves as chemical tools for investigating lipid metabolism pathways and fat digestion-related enzymes.

Lipase Inhibitors are used by researchers in metabolism and endocrinology to test the lipase inhibition effects in in vitro models and lipid biochemistry studies, including research on body weight regulation and energy homeostasis. Compounds such as JZL 184 and A 922500 are also used as selective probes to study the roles of MAGL and DGAT in lipid signaling pathways in pharmacology research laboratories.

Example products in this collection: TCI W0025 947669-91-2 WWL 70, TCI C2745 282526-98-1 Cetilistat, TCI A3468 1469924-27-3 3-[4'-(Dimethylamino)[1,1'-biphenyl]-3-yl]-1,1-dimethylurea, TCI D5994 959122-11-3 A 922500, TCI O0381 96829-58-2 Orlistat, TCI J0038 1101854-58-3 JZL 184.

Pay attention to the purity and physical form of the compounds (solid, viscous oil, or hydrochloride salt), as well as the clarity of stereochemistry in chiral molecules, so that enzyme inhibition test results are consistent and reproducible. All products are genuine Tokyo Chemical Industry (TCI) Japan products, with purity, packaging, and storage conditions listed on each item's page.

Other parallel categories under Obesity and Diabetes Research, often used together in a single laboratory workflow:

Back to Obesity and Diabetes Research. For large-volume procurement, special packaging, or specific grades, contact the AMI Scientific team — official TCI Japan distributor in Indonesia — for availability checks and direct lead times from Japan.

3 products